# Summary of best evidence for nutritional management in adult patients undergoing continuous renal replacement therapy

**Authors:** Liwei Jia, Jiangnan Wei, Kang Zhu, Xue Wang, Yuejuan Sun

PMC · DOI: 10.3389/fmed.2026.1749845 · 2026-02-20

## TL;DR

This study summarizes the best available evidence for nutritional management of adult patients receiving continuous renal replacement therapy to guide clinical protocols.

## Contribution

The study synthesizes current evidence to provide a comprehensive reference for nutritional management in CRRT patients.

## Key findings

- 12 documents were analyzed, yielding 16 evidence points across three nutritional management domains.
- Evidence covers nutritional assessment, energy/protein provision, and electrolyte/micronutrient monitoring.
- Personalized nutritional plans are recommended to improve patient outcomes.

## Abstract

To retrieve, screen, appraise, and synthesize the best evidence on nutritional management for adult patients undergoing continuous renal replacement therapy (CRRT) to inform the development of standardized clinical nutrition management protocols for CRRT.

Using the 5S evidence pyramid model, we conducted a top-down search of domestic and international sources, including databases of systematic reviews, guideline portals, professional association websites, and comprehensive databases, to identify clinical decision aids, evidence summaries, guidelines, standards, protocols, systematic reviews, and expert consensus statements. The search period was from January 1, 2006, to December 31, 2025. Two evidence-based nursing experts independently performed quality appraisal, evidence extraction, and grading for the included literature.

A total of 12 documents were included: one clinical decision aid, one evidence summary, eight guidelines, and two expert consensus statements. After systematic extraction and integration of the relevant evidence, 16 evidence points were summarized across three domains: nutritional assessment and selection of nutritional pathways, energy and protein provision, and monitoring and supplementation of electrolytes and micronutrients.

The best available evidence on nutritional management for adults undergoing CRRT synthesized in this study is comprehensive and scientifically sound. It provides a reference for clinical practice. However, personalized nutritional plans should be developed based on patients' clinical conditions to improve outcomes.

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** bleeding (MESH:D006470), multi-organ injury (MESH:D009102), arrhythmias (MESH:D001145), AKI (MESH:D058186), PEW (MESH:D011502), nutritional loss (MESH:D009748), hyperglycemia (MESH:D006943), critically ill (MESH:D016638), Hypomagnesemia (OMIM:613882), Kidney Disease (MESH:D007674), hypocalcemia (MESH:D006996), malnutrition (MESH:D044342), hyperglycemic (MESH:D006944), CRRT (MESH:D014202), Hypophosphatemia (MESH:D017674)
- **Chemicals:** water (MESH:D014867), propofol (MESH:D015742), Vitamin C (MESH:D001205), copper (MESH:D003300), phosphorus (MESH:D010758), phosphate (MESH:D010710), zinc (MESH:D015032), lactate (MESH:D019344), citrate (MESH:D019343), vitamin B6 (MESH:D025101), magnesium (MESH:D008274), glucose (MESH:D005947), folate (MESH:D005492), calcium (MESH:D002118), (A, D, E, K (-), carnitine (MESH:D002331), amino acid (MESH:D000596), thiamine (MESH:D013831), selenium (MESH:D012643)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12964707